Michael Gitlin, MD

Clinical Update

On, Off, and On Again: The Hidden Risks of Antidepressant Discontinuation

October 1, 2026

Victoria Hendrick, MD and Michael Gitlin, MD

Victoria Hendrick, MD. Chief, Inpatient Psychiatry, Olive View-UCLA Medical Center; Editor-in-Chief, The Carlat Hospital Psychiatry Report.

Michael J. Gitlin, MD. Distinguished Professor of Clinical Psychiatry; Director, Mood Disorders Clinic, Geffen School of Medicine, Los Angeles, CA.

Dr. Hendrick and Dr. Gitlin have no financial relationships with companies related to this material.

What do you do when a patient restarts an antidepressant, only to find it doesn't work as well the second time around?

Using Lithium in Older Adults With Chronic Kidney Disease

January 1, 2026

Michael Gitlin, MD

Distinguished Professor of Clinical Psychiatry; Director, Mood Disorders Clinic, Geffen School of Medicine, Los Angeles, CA.

Dr. Gitlin has no financial relationships with companies related to this material.

Lithium remains a powerful mood stabilizer in late life, but aging kidneys change the equation. Dr. Michael Gitlin reviews kidney-conscious dosing, monitoring by eGFR, and shared decision-making strategies to balance lithium’s benefits against renal risk in older adults.

When First-Line Depression Treatments Don’t Cut It: Newer Antidepressants and Sometimes, Antipsychotics

July 1, 2017

Michael Gitlin, MD

Michael Gitlin, MD Director of the Outpatient Mood Disorder Program at UCLA, as well as author of The Psychotherapist’s Guide to Psychopharmacology (Free Press) Dr. Gitlin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

You’ve tried different SSRIs and then some, but your patient either can’t tolerate what you’ve prescribed or simply hasn’t experienced a lift in mood. Now what? Dr. Gitlin has some ideas.